ID   DANi011-A
AC   CVCL_XJ28
SY   DANi-011A; LRRK2-011-C1
DR   BioSamples; SAMEA5912483
DR   hPSCreg; DANi011-A
DR   Wikidata; Q93503263
RX   PubMed=32305865;
CC   From: Danish Research Institute of Translational Neuroscience, Aarhus University; Aarhus; Denmark.
CC   Sequence variation: Mutation; HGNC; 18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=32305865).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=32305865
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 9,13
ST   D16S539: 9,12
ST   D21S11: 27,32.2
ST   D5S818: 10,12
ST   D7S820: 9,10
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 7
//
RX   PubMed=32305865; DOI=10.1016/j.scr.2020.101781;
RA   Chen M., Maimaitili M., Buchholdt S.H., Jensen U.B., Febbraro F.,
RA   Denham M.;
RT   "Generation of an induced pluripotent stem cell line (DANi-011A) from
RT   a Parkinson's disease patient with a LRRK2 p.G2019S mutation.";
RL   Stem Cell Res. 45:101781-101781(2020).
//